{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:31:49Z","timestamp":1788928309020,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12664-024-01678-z","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T06:01:43Z","timestamp":1727762503000},"page":"95-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic and predictive significance of p53 and ATRX in neuroendocrine neoplasms of GIT and pancreas and their utility as an adjunct to accurate diagnosis\u2014An eight-year retrospective study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7859-0782","authenticated-orcid":false,"given":"Divya Achutha","family":"Ail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-2288","authenticated-orcid":false,"given":"Roopa Rachel","family":"Paulose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"1678_CR1","volume-title":"WHO classification of tumours of the digestive system","author":"D Lokuhetty","year":"2018","unstructured":"Lokuhetty D, White V, Watanabe R. WHO classification of tumours of the digestive system. 5th ed. Lyon: International Agency for Research on Cancer; 2018.","edition":"5"},{"key":"1678_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12885-019-6498-z","volume":"20","author":"K Nielsen","year":"2020","unstructured":"Nielsen K, Binderup T, Langer SW, et al. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms. BMC Cancer. 2020;20:27. https:\/\/doi.org\/10.1186\/s12885-019-6498-z.","journal-title":"BMC Cancer"},{"key":"1678_CR3","doi-asserted-by":"publisher","unstructured":"Tang LH, Basturk O, Sue JJ, Klimstra DS. A practical approach to the classification of WHO grade 3 (G3) well-differentiated neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas. Am J Surg Pathol. 2016;40:1192\u2013202. https:\/\/doi.org\/10.1097\/pas.0000000000000408.","DOI":"10.1097\/pas.0000000000000408"},{"key":"1678_CR4","doi-asserted-by":"publisher","first-page":"26191","DOI":"10.1038\/srep26191","volume":"6","author":"AJ Cole","year":"2016","unstructured":"Cole AJ, Dwight T, Gill AJ, et al. Assessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing. Sci Rep. 2016;6:26191. https:\/\/doi.org\/10.1038\/srep26191.","journal-title":"Sci Rep"},{"key":"1678_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S, et al. A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer. 2015;113:299\u2013310. https:\/\/doi.org\/10.1038\/bjc.2015.190.","journal-title":"Br J Cancer"},{"key":"1678_CR6","doi-asserted-by":"publisher","first-page":"e0187667","DOI":"10.1371\/journal.pone.0187667","volume":"12","author":"AS Ali","year":"2017","unstructured":"Ali AS, Gr\u00f6nberg M, Federspiel B, et al. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma. PLoS One. 2017;12:e0187667. https:\/\/doi.org\/10.1371\/journal.pone.0187667.","journal-title":"PLoS ONE"},{"key":"1678_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/modpathol.3880324","volume":"14","author":"YS Bian","year":"2001","unstructured":"Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. \u00a0P53 gene mutation and protein accumulation during neoplastic progression in Barrett\u2019s esophagus. Mod Pathol. 2001;14:397\u2013403. https:\/\/doi.org\/10.1038\/modpathol.3880324.","journal-title":"Mod Pathol"},{"key":"1678_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1530\/ERC-15-0119","volume":"22","author":"M Heetfeld","year":"2015","unstructured":"Heetfeld M, Chougnet CN, Olsen IH, et al. Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2015;22:657\u201364. https:\/\/doi.org\/10.1530\/ERC-15-0119.","journal-title":"Endocr Relat Cancer"},{"key":"1678_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524:47\u201353. https:\/\/doi.org\/10.1038\/nature14664.","journal-title":"Nature"},{"key":"1678_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1155\/2021\/2510195","volume":"15","author":"J Li","year":"2021","unstructured":"Li J, Wang J, Su D, et al. P53 immunohistochemistry patterns are surrogate biomarkers for TP53 mutations in gastrointestinal neuroendocrine neoplasms.\u00a0Gastroenterol Res Pract. 2021;2021:2510195. \u00a0https:\/\/doi.org\/10.1155\/2021\/2510195.","journal-title":"Gastroenterol Res Pract"},{"key":"1678_CR11","doi-asserted-by":"publisher","first-page":"8238","DOI":"10.1002\/cam4.5633","volume":"12","author":"Q Dai","year":"2023","unstructured":"Dai Q, Zhang J, Long W, Haybaeck J, Yang Z.\u00a0Genetic alterations of GI-NECs involving three main signaling pathways. Cancer Med. 2023;12:8238\u201350. https:\/\/doi.org\/10.1002\/cam4.5633.","journal-title":"Cancer Med"},{"key":"1678_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/pin.13252","volume":"72","author":"M Tanaka","year":"2022","unstructured":"Tanaka M, Shinozaki-Ushiku A, Kunita A, et al. High-grade transformation of pancreatic neuroendocrine tumor associated with TP53 mutations: a diagnostic pitfall mimicking neuroendocrine carcinoma. Pathol Int. 2022;72:411\u20138. https:\/\/doi.org\/10.1111\/pin.13252.","journal-title":"Pathol Int"},{"key":"1678_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.humpath.2019.12.002","volume":"96","author":"AM Bellizzi","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2019.12.002.","journal-title":"Hum Pathol"},{"key":"1678_CR14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.1200609","volume":"331","author":"Y Jiao","year":"2011","unstructured":"Jiao Y, Shi C, Edil BH, et al. DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331:1199\u2013203. https:\/\/doi.org\/10.1126\/science.1200609.","journal-title":"Science"},{"key":"1678_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cncy.21982","volume":"126","author":"CS Sigel","year":"2018","unstructured":"Sigel CS, Krauss Silva VW, Reid MD, et al. Well differentiated grade 3 pancreatic neuroendocrine tumors compared with related neoplasms: a morphologic study. Cancer Cytopathol. 2018;126:326\u201335. https:\/\/doi.org\/10.1002\/cncy.21982.","journal-title":"Cancer Cytopathol"},{"key":"1678_CR16","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","volume":"23","author":"JY Kim","year":"2017","unstructured":"Kim JY, Brosnan-Cashman JA, An S, et al. Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival. Clin Cancer Res. 2017;23:1598\u2013606. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1147.","journal-title":"Clin Cancer Res"},{"issue":"600\u20139","key":"1678_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1158\/1078-0432.CCR-16-1113","volume":"23","author":"AD Singhi","year":"2017","unstructured":"Singhi AD, Liu T-C, Roncaioli JL, et al. Alternative lengthening of telomeres and loss of DAXX\/ATRX expression predicts metastatic disease and poor survival in patients with pancreatic neuroendocrine tumors. Clin Cancer Res. 2017;23:600\u20139.\u00a0https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1113.","journal-title":"Clin Cancer Res"},{"key":"1678_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7314\/APJCP.2013.14.1.419","volume":"14","author":"SZ Liu","year":"2013","unstructured":"Liu SZ, Zhang F, Chang YX, et al. Prognostic impact of cyclin D1, cyclin E and P53 on gastroenteropancreatic neuroendocrine tumours. Asian Pac J Cancer Prev. 2013;14:419\u201322. https:\/\/doi.org\/10.7314\/APJCP.2013.14.1.419.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1678_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/bjc.2016.229","volume":"115","author":"N Vijayvergia","year":"2016","unstructured":"Vijayvergia N, Boland PM, Handorf E, et al. Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study. Br J Cancer. 2016;115:564\u201370. https:\/\/doi.org\/10.1038\/bjc.2016.229.","journal-title":"Br J Cancer"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-024-01678-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-024-01678-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T08:54:03Z","timestamp":1740214443000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-024-01678-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1678"],"URL":"https:\/\/doi.org\/10.1007\/s12664-024-01678-z","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DAA and RRP\u00a0declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the Declaration of Helsinki 1964 and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and ethical approval"}},{"value":"ECASM-AIMS-2022\u2013241 Date: 01.11.2022.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional ethical approval"}},{"value":"Obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}